New Blood Test for Colorectal Cancer Screening

FDA approves new blood test for colorectal cancer screening, offering a simpler and less invasive option compared to colonoscopy. The test has an 83% sensitivity for detecting colorectal cancer.

Breakthrough in Cancer Detection

A major breakthrough in cancer research could lead to earlier detection and prevention of the disease using a simple blood test, identifying proteins in the blood that could warn of cancer years before diagnosis. This could revolutionize cancer treatment and prevention strategies.

New Blood Test for Colorectal Cancer Detection

A new blood test called SHIELD can detect colorectal cancer with over 80% accuracy, offering a less invasive screening option for average-risk individuals. The test is not recommended for high-risk groups.

New Blood Test for Colorectal Cancer Screening

A new blood test developed by Guardant Health could become another screening option for colorectal cancer if approved by the FDA. The test detects 83% of people with colorectal cancer and could help improve early detection. However, it will not replace colonoscopies as the next step if the test is positive.

Development of Blood Tests for Mental Health Disorders

Researchers at Johns Hopkins are developing a blood test to detect mental health disorders by analyzing genetic material in human blood. The study focuses on extracellular vesicles carrying specific mRNA linked to brain disorders, aiming to provide a non-invasive diagnostic tool. Another study by Cambridge University combines an online assessment with a blood test to diagnose bipolar disorder accurately. Additionally, scientists at Indiana University have created a blood test to measure anxiety objectively and identify effective treatment options. Yale University researchers have identified 170 genes linked to depression, potentially leading to a blood test for diagnosis and personalized treatment.